Theseus Pharmaceuticals, Inc.
NASDAQ:THRX
4.065 (USD) • At close February 13, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||||
| Nettowinst
| -13.504 | -14.805 | -14.586 | -13.717 | -14.745 | -11.649 | -10.497 | -8.656 | -7.372 | -6.807 | -4.473 | -2.89 | -1.429 |
| Afschrijvingen & Amortisatie
| 0.022 | 0.021 | 0.02 | 0.02 | 0.018 | 0.011 | 0.001 | 0.001 | 0 | 0 | 0.001 | 0 | 0.001 |
| Uitgestelde Inkomstenbelasting
| -1.734 | -1.242 | 0 | 0 | 0 | 0 | 0 | 4.248 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 3.64 | 3.573 | 2.993 | 2.375 | 4.475 | 2.518 | 2.044 | 1.584 | 1.293 | 0.936 | 0.548 | 0.784 | 0.033 |
| Verandering in Werkkapitaal
| 0.356 | 2.361 | -6.459 | 1.746 | 2.774 | 1.103 | 0.928 | -2.843 | 0.758 | -0.887 | -1.276 | 0.869 | 0.16 |
| Vorderingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Voorraden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| -1.052 | 0.191 | -2.799 | 3.153 | 0.314 | 0.081 | 0.423 | -0.987 | 0.59 | 0.369 | -0.122 | 0.849 | 0.044 |
| Overig Werkkapitaal
| 1.408 | 2.17 | 2.799 | -1.407 | 2.46 | 1.022 | 0.505 | -1.856 | 0.168 | -1.256 | -1.154 | 0.02 | 0.116 |
| Overige Niet-Contante Posten
| 0.194 | 0.053 | -0.598 | -0.361 | 0.252 | -0.081 | -0.16 | -4.248 | 0 | 0 | 0 | -0.001 | 0 |
| Kasstroom uit Operationele Activiteiten
| -11.026 | -10.039 | -18.63 | -9.937 | -7.226 | -8.098 | -7.684 | -9.914 | -5.321 | -6.758 | -5.2 | -1.238 | -1.235 |
| Investeringsactiviteiten: | |||||||||||||
| Investeringen in Materiële Vaste Activa
| -0.05 | -0.011 | 0.011 | -0.011 | -0.063 | -0.354 | -0.027 | 0.012 | 0 | 0 | 0 | 0 | 0 |
| Netto Overnames
| 0 | 0.052 | 0 | 166.894 | -49.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -9.624 | -83.42 | -56.64 | -36.123 | -61.839 | -2.807 | -90.67 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 19.751 | 31.492 | 40.877 | 25 | 49.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 0 | -0.052 | -0.011 | -166.894 | 49.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| 10.077 | -51.939 | -15.763 | -11.134 | -12.302 | -3.161 | -90.697 | 0.012 | 0 | 0 | 0 | 0 | 0 |
| Financieringsactiviteiten: | |||||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 0 | 0.142 | 49.438 | 0 | 0 | 0 | 0 | 99.892 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 0 | 0 | 0.048 | 0 | 0 | 0 | 0 | 64.281 | -1.483 | 1.195 | 99.892 | 3.998 | 4.997 |
| Kasstroom uit Financieringsactiviteiten
| 0 | 0.142 | 49.486 | 0 | 0 | 0 | 0 | 164.173 | -1.483 | 1.195 | 99.892 | 3.998 | 4.997 |
| Overige Informatie: | |||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | -0.001 | 0 | -0.012 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -0.949 | -61.836 | 15.093 | -20.959 | -19.527 | -11.19 | -98.381 | 154.259 | -6.804 | -5.563 | 94.692 | 2.76 | 3.762 |
| Kaspositie aan het Einde van de Periode
| 47.292 | 48.241 | 110.077 | 94.984 | 115.943 | 135.47 | 146.66 | 245.041 | 90.782 | 97.586 | 103.149 | 8.457 | 5.697 |